Developer of cardiovascular drugs. The company develops drug molecular screening technologies and has drugs on clinical trail 2 and clinical trail 1, providing patients with innovative drugs to treat their diseases.
What you see here scratches the surface
We’ll help you find what you need
This information is available in the PitchBook Platform. To explore Pharmavan‘s full profile, request access.
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
© 2022 PitchBook. Win what’s next. All rights reserved.